Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents

Oncogene

Volumn 23, Issue 39, 2004, Pages 6548-6558

  Nitta, Masayuki ^a   Kobayashi, Osamu ^a   Honda, Shinobu ^a   Hirota, Toru ^a   Kuninaka, Shinji ^a   Marumoto, Tomotoshi ^a   Ushio, Yukitaka ^a   Saya, Hideyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

BubR1; DNA damage; Mitotic catastrophe; p53; Spindle checkpoint; Time lapse

Indexed keywords

ANTINEOPLASTIC AGENT; BUB1 RELATED PROTEIN; PROTEIN P53; PRIMER DNA;

ANAPHASE; ARTICLE; CANCER CELL; CANCER GENETICS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CENTROMERE; CHROMOSOME; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; HUMAN CELL; METAPHASE; MITOSIS INHIBITION; MITOSIS SPINDLE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HELA CELL; MITOSIS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

BASE SEQUENCE; DNA DAMAGE; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; MITOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4444245817     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207873     Document Type: Article

References (41)

1. Anand S, Penrhyn-Lowe S and Venkitaraman AR. (2003). Cancer Cell, 3, 51-62.
2. Borel F, Lacroix FB and Margolis RL. (2002). J. Cell Sci., 115, 2829-2838.
3. Brachman DG, Beckett M, Graves D, Haraf D, Yokes E and Weichselbaum RR. (1993). Cancer Res., 53, 3667-3669.
4. Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG and Carey TE. (2003). Head Neck, 25, 654-661.
5. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B. (1998). Science, 282, 1497-1501.
6. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW and Vogelstein B. (1999). J. Clin. Invest., 104, 263-269.
7. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B. (1998). Nature, 392, 300-303.
8. Chan TA, Hermeking H, Lengauer C, Kinzler KW and Vogelstein B. (1999). Nature, 401, 616-620.
9. Chan TA, Hwang PM, Hermeking H, Kinzler KW and Vogelstein B. (2000). Genes Dev., 14, 1584-1588.
10. den Elzen N and Pines J. (2001). J. Cell Biol, 153, 121-136.
11. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
12. Erenpreisa JE, Ivanov A, Dekena G, Vitina A, Krampe R, Freivalds T, Selivanova G and Roach HI. (2000). Cell Biol. Int., 24, 61-70.
13. Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace Jr AJ, Magrath I, Kohn KW and O'Connor PM. (1994). Cancer Res., 54, 5824-5830.
14. Fan S, Smith ML, Rivet DJ, Duba II D, Zhan Q, Kohn KW, Fornace Jr AJ and O'Connor PM. (1995). Cancer Res., 55, 1649-1654.
15. Fingert HJ, Chang JD and Pardee AB. (1986). Cancer Res., 46, 2463-2467.
16. Garber PM and Rine J. (2002). Genetics, 161, 521-534.
17. Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki T, Takahashi T and Inagaki M. (1999). J. Biol. Chem., 274, 25543-25549.
18. Haber JE. (1999). Trends Biochem. Sci., 24, 271-275.
19. Kapoor TM, Mayer TU, Coughlin ML and Mitchison TJ. (2000). J. Cell Biol, 150, 975-988.
20. Lens SM, Wolthuis RM, Klompmaker R, Kauw J, Agami R, Brummelkamp T, Kops G and Medema RH. (2003). EMBO J., 22, 2934-2947.
21. Li Y and Benezra R. (1996). Science, 274, 246-248.
22. Maringele L and Lydall D. (2002). Genes Dev., 16, 1919-1933.
23. Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E and Saya H. (2003). J. Biol. Chem., 278, 51786-51795.
24. Masuda A, Maeno K, Nakagawa T, Saito H and Takahashi T. (2003). Am. J. Pathol, 163, 1109-1116.
25. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV and Benezra R. (2001). Nature, 409, 355-359.
26. Mikhailov A, Cole RW and Rieder CL. (2002). Curr. Biol., 12, 1797-1806.
27. O'Connor DS, Wall NR, Porter AC and Altieri DC. (2002). Cancer Cell, 2, 43-54.
28. Rogakou EP, Boon C, Redon C and Bonner WM. (1999). J. Cell Biol., 146, 905-916.
29. Rogakou EP, Pilch DR, Orr AH, Ivanova VS and Bonner WM. (1998). J. Biol. Chem., 273, 5858-5868.
30. Roninson IB, Broude EV and Chang BD. (2001). Drug Resist. Update, 4, 303-313.
31. Ru HY, Chen RL, Lu WC and Chen JH. (2002). Oncogene, 21, 4673-4679.
32. Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S and Matsuzawa Y. (2002). Cancer, 94, 2047-2054.
33. Sausville EA, Arbuck SG, Messmann R, Headlee D, Bauer KS, Lush RM, Murgo A, Figg WD, Lahusen T, Jaken S, Jing X, Roberge M, Fuse E, Kuwabara T and Senderowicz AM. (2001). J. Clin. Oncol, 19, 2319-2333.
34. Servomaa K, Kiuru A, Grenman R, Pekkola-Heino K, Pulkkinen JO and Rytomaa T. (1996). Cell Prolif., 29, 219-230.
35. Shannon KB, Canman JC and Salmon ED. (2002). Mol. Cell. Biol, 13, 3706-3719.
36. Sudo T, Nitta M, Saya H and Ueno NT. (2004). Cancer Res., 64, 2502-2508.
37. Takahashi T, Haruki N, Nomoto S, Masuda A, Saji S and Osada H. (1999). Oncogene, 18, 4295-4300.
38. Toledo F, Coquelle A, Svetlova E and Debatisse M. (2000). Nucleic Acids Res., 28, 4805-4813.
39. Vogt U, Zaczek A, Klinke F, Granetzny A, Bielawski K and Falkiewicz B. (2002). J. Cancer Res. Clin. Oncol., 128, 141-147.
40. Wang H, Liu D, Wang Y, Qin J and Elledge SJ. (2001). Genes Dev., 15, 1361-1372.
41. Wang X, Jin DY, Ng RW, Feng H, Wong YC, Cheung AL and Tsao SW. (2002). Cancer Res., 62, 1662-1668.